Many women with breast cancer, especially those treated with chemotherapy, experience cognitive decline due in part to neurotoxic brain injury. Recent neuroimaging studies suggest widespread brain structural abnormalities pointing to disruption of large-scale brain networks. We applied resting state functional magnetic resonance imaging and graph theoretical analysis to examine the connectome in breast cancer survivors treated with chemotherapy relative to healthy comparison women. Compared to healthy females, the breast cancer group displayed altered global brain network organization characterized by significantly decreased global clustering as well as disrupted regional network characteristics in frontal, striatal and temporal areas. Breast cancer survivors also showed significantly increased self-report of executive function and memory difficulties compared to healthy females. These results suggest that topological organization of both global and regional brain network properties may be disrupted following breast cancer and chemotherapy. This pattern of altered network organization is believed to result in reduced efficiency of parallel information transfer. This is the first report of alterations in large-scale functional brain networks in this population and contributes novel information regarding the neurobiologic mechanisms underlying breast cancer-related cognitive impairment.
Introduction
Cognitive deficit is a common complication following breast cancer chemotherapy with as many as 75% of patients experiencing significant deficits (Janelsins et al., 2011) . The most frequently observed impairments include executive functioning and memory deficits although difficulties in other cognitive domains have also been reported (Janelsins et al., 2011; Wefel et al., 2010) . Chemotherapy-treated patients are up to 8 times more likely to experience cognitive deficit compared to non-chemotherapy treated patients (Schagen et al., 2006; Stewart et al., 2008) . Although chemotherapeutic agents typically have restricted direct access to brain tissue due to the blood-brain barrier, animal studies indicate that even chemotherapeutic agents that are not known to readily cross the blood-brain barrier (e.g. doxorubicin) are associated with reduced neurogenesis (Janelsins et al., 2010) . Both dividing and non-dividing neural and glial cells are significantly vulnerable to chemotherapies (Dietrich, 2010; Dietrich et al., 2006; Seigers et al., 2008 Seigers et al., , 2009 Winocur et al., 2006) and even small amounts of chemotherapy in the brain may cause long-term damage (Dietrich, 2010) . Accordingly, emerging data suggest that breast cancer chemotherapy is associated with diffuse structural injury including widespread decreases in gray matter volume (McDonald et al., 2010) and white matter integrity (Deprez et al., 2011) . A pattern of diffuse damage is likely to disrupt overall brain organization, reducing efficiency of information transfer. Previous studies have suggested that breast cancer survivors show decreased efficiency of neural networks, requiring more functional activation across a range of brain regions to complete certain tasks compared to healthy women (Cimprich et al., 2010; Kesler et al., 2009; Silverman et al., 2007) . The specific pattern of brain changes following breast cancer and chemotherapy, including global versus local deficits, would have important implications for developing the most effective interventions for breast cancer-related cognitive deficits. Elucidation of large-scale brain network configuration in breast cancer may therefore contribute important new information regarding the neurobiologic mechanisms of breast cancer-related cognitive impairment.
However, it is currently unknown whether breast cancer and/or its treatments disrupt the organization of whole-brain networks. Previous studies of healthy individuals as well as certain pathological conditions have consistently revealed that brain networks are organized in a small-world manner characterized by high local specialization combined with high capacity for global information transfer (Bullmore and Bassett, 2011; Sporns, 2011) . This organizational scheme allows for high efficiency of parallel processes with low wiring or energy costs (Guye et al., 2010) . Evaluation of these Neurobiology of Disease 48 (2012) 329-338 
